Andere Sprachen VBI Vaccines Inc.

Aktien

A3D9SJ

CA91822J2020

VBIV

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 30.04.2024			% 5 Tage	% 1. Jan.
0.571 ^USD	+1.24%		-6.16%	-2.81%

16.04.	VBI Vaccines Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
03.04.	VBI Vaccines Inc. präsentiert ermutigende Daten zum frühen Tumoransprechen aus der randomisierten, kontrollierten Phase-2b-Studie von VBI-1901 bei rezidivierendem Glioblastom	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

VBI Vaccines : 2023 Annual Report	17.04.
VBI Vaccines Reports Full Year 2023 Financial Results	16.04.
VBI Vaccines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	16.04.
North American Morning Briefing : Stock Futures -2-	15.04.
VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	11.04.
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	09.04.
North American Morning Briefing : Inflation Data, -2-	08.04.
VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma	03.04.
VBI Vaccines Inc. Presents Encouraging Early Tumor Response Data from Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma	03.04.
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform - VBI Vaccines	03.04.
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform	02.04.
VBI Vaccines Inc. Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA- Launched eVLP Vaccine Platform	02.04.
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results	25.03.
North American Morning Briefing : Tech in Focus on -2-	25.03.
North American Morning Briefing : Investors -2-	18.03.
North American Morning Briefing : Stock Futures -2-	11.03.
Brii Biosciences Announces Agreements To Acquire VBI Vaccines' IP Rights In BRII-179	05.03.
Thinking about buying stock in Arena Group, Dunxin Financial Holdings, Nano-X Imaging, VBI Vaccines, or SuRo Capital?	15.02.
VBI Vaccines Sells Rights to Hepatitis B Vaccine to Brii Biosciences	14.02.
VBI Vaccines Inc. Enter into New License Agreement with Brii Biosciences	14.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen VBI Vaccines Inc.

Aktien

A3D9SJ

CA91822J2020

VBIV

Andere Sprachen

Filter